Related references
Note: Only part of the references are listed.Recombinant Anthrax Toxin Receptor-Fc Fusion Proteins Produced in Plants Protect Rabbits against Inhalational Anthrax
Keith L. Wycoff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome
Zachary L. Newman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
A case of septicaemic anthrax in an intravenous drug user
Arfon G. M. T. Powell et al.
BMC INFECTIOUS DISEASES (2011)
The Poly-γ-D-Glutamic Acid Capsule of Bacillus anthracis Enhances Lethal Toxin Activity
Jeyoun Jang et al.
INFECTION AND IMMUNITY (2011)
Charge Requirements for Proton Gradient-driven Translocation of Anthrax Toxin
Michael J. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits
Haim Levy et al.
MICROBIAL PATHOGENESIS (2011)
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
Jody D. Berry et al.
NEW BIOTECHNOLOGY (2011)
MECHANISMS OF DISEASE Proprotein Convertases in Health and Disease
Andrew W. Artenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tumor Endothelial Marker 8 Amplifies Canonical Wnt Signaling in Blood Vessels
Kiran Verma et al.
PLOS ONE (2011)
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule
Zhaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
INTER-alpha INHIBITOR PROTEINS: A NOVEL THERAPEUTIC STRATEGY FOR EXPERIMENTAL ANTHRAX INFECTION
Steven M. Opal et al.
SHOCK (2011)
Anthrax lethal toxin activates the inflammasome in sensitive rat macrophages
Zachary L. Newman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cutting Edge: Resistance to Bacillus anthracis Infection Mediated by a Lethal Toxin Sensitive Allele of Nalp1b/Nlrp1b
Jill K. Terra et al.
JOURNAL OF IMMUNOLOGY (2010)
Anthrax Lethal and Edema Toxins Produce Different Patterns of Cardiovascular and Renal Dysfunction and Synergistically Decrease Survival in Canines
Daniel A. Sweeney et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
InFACT: a global critical care research response to H1N1
John C. Marshall et al.
LANCET (2010)
Interferon-Inducible CXC Chemokines Directly Contribute to Host Defense against Inhalational Anthrax in a Murine Model of Infection
Matthew A. Crawford et al.
PLOS PATHOGENS (2010)
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death
Ping Jun Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats
Yan Li et al.
CRITICAL CARE MEDICINE (2009)
Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax
Anette Schneemann et al.
FUTURE MICROBIOLOGY (2009)
Inactivation of Rho GTPases by Statins Attenuates Anthrax Lethal Toxin Activity
Aimee M. deCathelineau et al.
INFECTION AND IMMUNITY (2009)
Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody
Zhaochun Chen et al.
INFECTION AND IMMUNITY (2009)
Encapsulated Bacillus anthracis Interacts Closely with Liver Endothelium
Alejandro Piris-Gimenez et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes
Alexander F. Kintzer et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Gram-positive toxic shock syndromes
Emma Lappin et al.
LANCET INFECTIOUS DISEASES (2009)
Raxibacumab for the Treatment of Inhalational Anthrax.
Thi-Sau Migone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding
Zhaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bacteriophage lysins as effective antibacterials
Vincent A. Fischetti
CURRENT OPINION IN MICROBIOLOGY (2008)
Discovery and development of anthrax lethal factor metalloproteinase inhibitors
Benjamin E. Turk
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Thymosin alpha(1)- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria
Ying Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Inflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus
Chun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bench-to-bedside review: Quorum sensing and the role of cell-to-cell communication during invasive bacterial infection
Shadaba Asad et al.
CRITICAL CARE (2008)
Anthrax toxin evades Toll-like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers
Martha Triantafilou et al.
CELLULAR MICROBIOLOGY (2007)
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax
Mark T. Albrecht et al.
INFECTION AND IMMUNITY (2007)
Amiodarone and bepridil inhibit anthrax toxin entry into host cells
Ana M. Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model
Kevin Sherer et al.
CRITICAL CARE MEDICINE (2007)
Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction
Linley E. Watson et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Identification of an in vivo inhibitor of Bacillus anthracis spore germination
Monique Akoachere et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis
Jeffrey Tessier et al.
INFECTION AND IMMUNITY (2007)
LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin
John J. Young et al.
PLOS PATHOGENS (2007)
Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model
Xizhong Cui et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: A potential clinical marker and mediator of severe sepsis
Steven M. Opal et al.
CRITICAL CARE MEDICINE (2007)
Insertion of anthrax protective antigen into liposomal membranes - Effects of a receptor
Jianjun Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin
Wei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin
Mark I. Hirsh et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Cisplatin inhibition of anthrax lethal toxin
Mahtab Moayeri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways
Kaushik Chakrabarty et al.
INFECTION AND IMMUNITY (2006)
Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity
Matthew A. Crawford et al.
JOURNAL OF IMMUNOLOGY (2006)
Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production
Hui Fang et al.
JOURNAL OF IMMUNOLOGY (2006)
Systematic review: A century of inhalational anthrax cases from 1900 to 2005
JEC Holty et al.
ANNALS OF INTERNAL MEDICINE (2006)
Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice
Y Gozes et al.
INFECTION AND IMMUNITY (2006)
Anthrax toxins: a paradigm of bacterial immune suppression
Cosima T. Baldari et al.
TRENDS IN IMMUNOLOGY (2006)
Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo
JE Comer et al.
INFECTION AND IMMUNITY (2005)
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice
I Brook et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and Ilomastat block Bacillus anthracis lethal factor activity in viable cells
SS Kocer et al.
INFECTION AND IMMUNITY (2005)
Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets
JH Kau et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Receptor-specific requirements for anthrax toxin delivery into cells
GJA Rainey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Anthrax lethal toxin paralyzes neutrophil actin-based motility
RL During et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine
T Komiyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication
SM Opal et al.
INFECTION AND IMMUNITY (2005)
A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers
GM Subramanian et al.
CLINICAL INFECTIOUS DISEASES (2005)
Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin
M Moayeri et al.
INFECTION AND IMMUNITY (2005)
Inhibition of Bacillus anthracis growth and virulence-gene expression by inhibitors of quorum-sensing
MB Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge
N Mohamed et al.
INFECTION AND IMMUNITY (2005)
Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis
XZ Cui et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Potent inhibitors of anthrax lethal factor from green tea
I Dell'Aica et al.
EMBO REPORTS (2004)
Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats
XZ Cui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection
YQ Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
SF Little et al.
VACCINE (2004)
Protein translocation through anthrax toxin channels formed in planar lipid bilayers
S Zhang et al.
BIOPHYSICAL JOURNAL (2004)
Cytokine response to infection with Bacillus anthracis spores
AK Pickering et al.
INFECTION AND IMMUNITY (2004)
Chloroquine enhances survival in Bacillus anthracis intoxication
AW Artenstein et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis
YP Lim et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin
A Agrawal et al.
NATURE (2003)
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria
TD Read et al.
NATURE (2003)
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor
HM Scobie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-α
SO Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization
SH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human antibodies from immunized donors are protective against anthrax toxin in vivo
MA Wild et al.
NATURE BIOTECHNOLOGY (2003)
In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody
S Welkos et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2002)
Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells
P Kumar et al.
INFECTION AND IMMUNITY (2002)
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch et al.
NATURE (2002)
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
JA Maynard et al.
NATURE BIOTECHNOLOGY (2002)
Anthrax as a biological weapon, 2002 - Updated recommendations for management
TV Inglesby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Identification of the cellular receptor for anthrax toxin
KA Bradley et al.
NATURE (2001)
Crystal structure of the anthrax lethal factor
AD Pannifer et al.
NATURE (2001)
Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States
JA Jernigan et al.
EMERGING INFECTIOUS DISEASES (2001)
Designing a polyvalent inhibitor of anthrax toxin
M Mourez et al.
NATURE BIOTECHNOLOGY (2001)
Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax
BR Sellman et al.
SCIENCE (2001)
Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin
JL Erwin et al.
INFECTION AND IMMUNITY (2001)
Injectional anthrax in a heroin skin-popper
SH Ringertz et al.
LANCET (2000)
Intracellular calcium antagonist protects cultured peritoneal macrophages against anthrax lethal toxin-induced cytotoxicity
S Shin et al.
CELL BIOLOGY AND TOXICOLOGY (2000)
Share Paper
